Table 2.

Baseline clinical characteristics of the patients according to the C807T genotype

807 CC (n = 656) 807 CT (n = 839) 807 TT (n = 302) P
Age, y  63.8 ± 11.3 64.4 ± 10.2  65.6 ± 10.0  .05  
Women, %  23.9 21.7  19.9  .33  
Arterial hypertension, %  68.0 69.7  65.9  .45  
Diabetes, %  18.8  22.3  25.2 .06  
Active cigarette smokers, %  25.6  24.2  24.8 .82  
Hypercholesterolemia, %  39.6  42.4  44.0  .36 
Unstable angina, %  40.1  44.7  45.0  .15  
History of myocardial infarction, %  29.1  31.5  31.8  .56 
Previous bypass surgery, %  13.3  11.0  15.6  .09 
Reduced left ventricular function, %  43.3  44.2  52.6 .02  
Multivessel disease, %  73.8  77.1  79.1  .14 
Therapy with abciximab, %  13.4  13.9  11.9 .68 
807 CC (n = 656) 807 CT (n = 839) 807 TT (n = 302) P
Age, y  63.8 ± 11.3 64.4 ± 10.2  65.6 ± 10.0  .05  
Women, %  23.9 21.7  19.9  .33  
Arterial hypertension, %  68.0 69.7  65.9  .45  
Diabetes, %  18.8  22.3  25.2 .06  
Active cigarette smokers, %  25.6  24.2  24.8 .82  
Hypercholesterolemia, %  39.6  42.4  44.0  .36 
Unstable angina, %  40.1  44.7  45.0  .15  
History of myocardial infarction, %  29.1  31.5  31.8  .56 
Previous bypass surgery, %  13.3  11.0  15.6  .09 
Reduced left ventricular function, %  43.3  44.2  52.6 .02  
Multivessel disease, %  73.8  77.1  79.1  .14 
Therapy with abciximab, %  13.4  13.9  11.9 .68 

Age is mean ± SD; other variables are expressed as percentage of patients.

or Create an Account

Close Modal
Close Modal